• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Chemmedchem

    Chemmedchem

    JournalISSN 1860-7179eISSN 1860-7187中科院 医学 4区

    年发文量

    研究主题

    论文(6139)

    排序
    1Mining for Microbial Treasure: Recent Therapeutic Leads from Actinobacteria Isolated from the Biodiversity of Australia
    Yutong Zou, Nida Ahmed,Constance B. Bailey

    Australia is one of the most geographically isolated countries in the world, which has resulted in the evolution of a distinct microflora resulting from this unique biodiversity. Actinobacteria are historically one of the most prolific sources of microbial natural products, and the Actinobacteria isolated from Australian soil have led to the discovery of several novel bioactive compounds in recent years. The Australian ecosystem contains diverse rare and novel actinomycetes, including novel Streptomycetes , and most remain untapped for new compound discovery. This review summarizes novel natural products and analogs of previously reported compounds which isolated from Actinobacteria collected from isolates gathered across the Australian continent in recent 5 years and discusses the biological activities uncovered. These compounds should be further probed to gain insights about their mode of activity, thus identifying potential leads for next‐generation candidates for anticancer agents, antibiotics, and anthelmintics.

    2026
    引用
    AI阅读
    加入学术空间
    2Early Magnetic Resonance Imaging and Single‐Photon Emission Computerized Tomography Detection of Breast Cancer with Netrin‐1‐Specific Molecular and Liposome Probes
    Alexis Patou, Tea Lukačević,Agnès Pallier,Julien Sobilo,Sandra Même,Éva Tóth,Sara Lacerda

    Specific tumor biomarkers visualization by molecular magnetic resonance imaging (MRI) enables early cancer detection before morphologic changes appear. Herein, we designed a peptide targeting moiety (GEVMPTLDMALFDWTDYEDLKP) for the extracellular emerging biomarker Netrin‐1, which was first conjugated to a DOTA‐like chelator ( G ). 111 In‐ G highlighted small tumors in an orthotopic murine model of triple‐negative metastatic breast cancer (4T1) by single‐photon emission computerized tomography (SPECT). Nevertheless, 111 In‐ G had very high kidney uptake which prevailed 24 h post‐injection. To prevent potential toxicity for MRI Gd‐analog, injected in higher dose due to MRI’s low sensibility, we developed a novel targeted liposome formulation, ( 111 In)‐Gd‐L G . Liposomes contain PEGylated phospholipids functionalized with the new targeting peptide and amphiphilic Gd 3+ / 111 In 3+ chelates enabling multimodal MRI and/or SPECT detection. The formulation was optimized and characterized by dynamic light scattering and 1 H relaxometry. In the same 4T1 murine model, ex vivo biodistribution evidenced significantly reduced liposomes kidney uptake (4 vs. 137%ID/g for 111 In‐Gd‐L G versus 111 In‐ G , 4 h post injection), retaining tumor detection capabilities. Successful in vivo MRI visualization of small tumors (<50 mm 3 ) at 0.03 mmol/kg Gd dose, provided similar signal enhancement as the clinical agent Dotarem at a 7‐fold higher dose. Data reinforce Netrin‐1’s potential targeting as cancer‐specific imaging approaches.

    2026
    引用
    AI阅读
    加入学术空间
    3Defining the Structure–Activity Relationships of Thiazolide Antivirals: Balancing Potency, Metabolic Stability, and Aqueous Solubility
    Joshua Taujanskas,Sophie Pate,Andrew V. Stachulski,Sara Piacentini,Simone La Frazia,M. Gabriella Santoro,Paul M. O’Neill

    Recent studies on thiazolide antivirals have identified compounds RM5038 and RM5021 as potent inhibitors of hepatitis B virus (HBV), hepatitis C virus (HCV), and influenza A, although their development has been limited by poor aqueous solubility and rapid metabolic clearance. In this work, a series of novel halogen‐substituted and 4′‐alkylsulfone thiazolide analogs were synthesized using updated convergent synthetic approaches and flexible protecting group strategies. DMPK evaluation demonstrated that 3‐X halogen substitution significantly improved aqueous solubility in parallel to enhancing metabolic stability. Within the chlorothiazolide series, compounds 10g and 10l displayed much improved metabolic stability profiles, excellent aqueous solubility representing a 10‐fold improvement over the parent drug, together with low single‐digit micromolar antiviral (influenza A) activity and acceptable in vitro safety indices. Evaluation of the 4′‐alkylsulfone thiazolides also revealed improved in vitro DMPK profiles while retaining micromolar antiviral potency. SAR analysis indicated that short alkyl sulfone substituents containing two to three carbons are optimal for antiviral activity, while branched alkyl groups may provide additional metabolic advantages. In summary, compounds 10g, 10l, and 15d represent promising early leads for progression to in vivo profiling and additional preclinical evaluation.

    2026
    引用
    AI阅读
    加入学术空间
    4Immunoglobulin Light Chain Repertoire and Mutation Landscape in AL Amyloidosis: A Combined Proteomic and Computational Study of Kappa and Lambda Deposits
    Mariya Yu. Suvorina,Elena A. Stepanova,Anna V. Glyakina,Alexey K. Surin,Oxana V. Galzitskaya

    AL amyloidosis is a protein‐misfolding disorder caused by deposition of immunoglobulin light‐chain variable domains. Lambda chains account for ≈80% of cases and kappa for ≈20%. We performed high‐resolution mass spectrometry and bioinformatics on biopsies from 25 patients (15 kappa‐type, 9 lambda‐type, 1 mixed). We identified 42 unique IGKV and 11 IGLV sequences; IGKV3‐20, IGKV1‐39/1D‐39, and IGLV1‐40 were most frequent. Because immunoglobulin variable‐domain sequences are highly homologous, some identifications are reported at the family or subfamily level. Amino acid substitutions clustered in FR1 and FR3. Using FoldAmyloid, PASTA, AGGRESCAN, and Waltz, we evaluated the amyloidogenicity of native and mutant proteins. Several mutations altered aggregation: I70/54V in IGKV1 ‐ 27 abolished Waltz‐predicted amyloidogenic stretch, while T42/22L in IGKV1‐5 created a new AGGRESCAN hotspot. Notably, eight identified sequences (IGKV3‐7, IGKV1/OR2‐108, IGKV6D‐21, IGKV6‐21, IGKV1D‐42, IGKV6D‐41, IGKV3/OR2‐268, IGLV1‐50) are absent from the AL‐Base database, suggesting that rare germline variants may carry a higher amyloidogenic risk. Our study underscores the value of combining proteomics and computational analysis for precise amyloid typing and for identifying mutations that may influence disease progression.

    2026
    引用
    AI阅读
    加入学术空间
    5The Molecular Design of Type I Photosensitizers to Remodel Hypoxic Microenvironment for Advanced Cancer Theranostics
    Huihui Lu,Jingjing Zhang, Jiayao Zhao,Yanan Li,Feifei An,Yichao Chai

    Photodynamic therapy (PDT) is significantly constrained in hypoxic tumor microenvironments (TMEs) because conventional Type II photosensitization depends strongly on molecular oxygen for efficient singlet oxygen generation. This limitation has stimulated increasing interest in Type I photosensitizers, which initiate photochemical reactions through electron or hydrogen transfer and can retain reactive oxygen species (ROS)‐generating activity under reduced oxygen availability. In some Type I PDT systems, additional oxygen‐regulating processes can further alleviate local hypoxia, thereby sustaining O 2 − ‐dependent downstream ROS generation while contributing to the modulation of the TME. These properties also support combination strategies with photothermal therapy, immunotherapy, or chemotherapy to enhance therapeutic outcomes. This review systematically examines Type I photosensitizers within a framework linking molecular design, photophysical and photochemical properties, mechanistic pathways, and biomedical applications. Their classification, structure–property relationships, and mechanisms of action are critically examined, with particular emphasis on recent advances in hypoxia‐tolerant PDT, multimodal combination therapy, and imaging‐guided theranostics. Finally, the remaining challenges and future directions are discussed with the aim of facilitating the translation of Type I photosensitizers from fundamental research toward clinical cancer theranostics.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 6139 篇论文

    高被引作者

    作者引用发文
    Antoine Daina30872
    Vincent Zoete30872
    Chi-Ming Che19413
    Tam, Kwong Hang Paul19413
    Chi-Ming Ho19413
    Ian H Gilbert148022
    Alan Kozikowski135531
    Jun Tian13341
    Yu Wing-Yiu13341
    Lok C N13341

    高产作者

    作者引用发文
    Claudiu Trandafir Supuran61551
    Gerhard Klebe95838
    Maurizio Botta100235
    Antonello Mai55632
    Wünsch Bernhard55232
    Novellino Ettore84031
    Alan Kozikowski135531
    Jürgen Bajorath58431
    Klaus T. Wanner43930
    Manfred Jung103629

    相关期刊

    Bioorganic & Medicinal Chemistry
    Bioorganic & Medicinal Chemistry Letters
    Organic and Biomolecular Chemistry
    Expert opinion on therapeutic patents
    Future medicinal chemistry
    ACS medicinal chemistry letters
    Expert Opinion on Drug Discovery
    Journal of Inorganic Biochemistry
    Chembiochem
    RSC Medicinal Chemistry